Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, Part 16 of an ongoing series, Sharon R. Lewin, AO, FRACP, PhD, FAHMS, provides a brief update on emerging COVID-19 variants and their potential impacts on vaccine efficacy. After the update, Professor Lewin answers questions submitted by healthcare professionals on various aspects of COVID-19.
Sharon R. Lewin, AO, FRACP, PhD, FAHMS
Director, The Peter Doherty Institute for Infection and Immunity
Melbourne Laureate Professor of Infectious Diseases
University of Melbourne
Consultant Infectious Diseases Physician
Alfred Hospital and Royal Melbourne Hospital
In this presentation, Dr. Sharon Lewin reviews investigational therapies for COVID-19: TMPRSS2 inhibitors, CRISPR-Cas13, and interferon lambda.
Arthur Kim, MD, provides an update on the latest COVID-19 treatment options and guidelines and answers questions in the CCO Infectious Disease podcast
Dr. Vikram Mukherjee reviews recent studies on thromboprophylaxis and anticoagulation in persons with COVID-19, from Clinical Care Options (CCO)
Dr. Jens D. Lundgren reviews diagnostic tests for SARS-CoV-2 infection, contrasting antigen tests with nucleic acid assays, and describing how to use and interpret antigen tests from Clinical Care Options (CCO)